Ginkgo Bioworks Holdings, Inc.

Historical 13F Holders

Symbol
DNA
CUSIP
37611X209
All holders as of
Q2 2026
Type
Equity
Class
CL A NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 37611X209 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A Amendment 1 7.7% 7/30/2026
Event 6/30/2026
Viking Global Investors LP 13G/A Amendment 4
7.1% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 5 0% 3/26/2026
Event 3/13/2026
Baillie Gifford & Co 13G/A Amendment 7 4.9% 2/5/2026
Event 12/31/2025
Cascade Investment, L.L.C. 13G/A Amendment 1
7.5% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G 5.1% 7/29/2025
Event 6/30/2025
BlackRock, Inc. 13G 6.5% 7/17/2025
Event 6/30/2025
Austin Che 13G/A Amendment 4 5.0%
Checked 5% or less
2/14/2025
Event 12/31/2024
Reshma P. Shetty 13D/A Amendment 4
9.5% 2/14/2025
Event 2/14/2025
Vanguard Group Inc 13G/A Amendment 4 4.5% 1/30/2025
Event 12/31/2024
ARK Investment Management LLC 13G/A Amendment 3 0% 1/10/2025
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 17.0 k $218 k
2026 Q2 192 36.7 M $414 M
2026 Q1 182 32.3 M $197 M
2025 Q4 198 32.7 M $272 M
2025 Q3 192 30.4 M $441 M
2025 Q2 177 33.7 M $379 M
2025 Q1 180 32.3 M $184 M
2024 Q4 184 32.5 M $319 M
2024 Q3 172 26.3 M $214 M
2024 Q2 2 12.2 k $4.08 k